Health Catalyst, Inc Common Stock (HCAT) is a publicly traded Healthcare sector company. As of May 21, 2026, HCAT trades at $1.29 with a market cap of $93.85M and a P/E ratio of -0.34. HCAT moved +2.36% today. Year to date, HCAT is -43.67%; over the trailing twelve months it is -67.26%. Its 52-week range spans $0.96 to $9.24. Analyst consensus is neutral with an average price target of $2.11. Rallies surfaces HCAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Health Catalyst, Inc Common Stock (HCAT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. HCAT moved +2.36% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $1.29 |
| Market Cap | $93.85M |
| P/E Ratio | -0.34 |
| EPS | $-3.74 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.24 |
| 52-Week Low | $0.96 |
| Volume | 347.53K |
| Avg Volume | 0 |
| Revenue (TTM) | $302.48M |
| Net Income | $-265.26M |
| Gross Margin | 0.00% |
9 analysts cover HCAT: 0 strong buy, 2 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $2.11.